• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

miR-205-5p 的下调和上调特征在浸润性导管乳腺癌患者的播散肿瘤细胞中。

miR-205-5p Downregulation and Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer.

机构信息

Department of Genetics, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 84505 Bratislava, Slovakia.

Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 84505 Bratislava, Slovakia.

出版信息

Int J Mol Sci. 2021 Dec 22;23(1):103. doi: 10.3390/ijms23010103.

DOI:10.3390/ijms23010103
PMID:35008529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8744876/
Abstract

BACKGROUND

Dissemination of breast cancer (BC) cells through the hematogenous or lymphogenous vessels leads to metastatic disease in one-third of BC patients. Therefore, we investigated the new prognostic features for invasion and metastasis.

METHODS

We evaluated the expression of miRNAs and epithelial-to-mesenchymal transition (EMT) genes in relation to /E-cadherin changes in samples from 31 patients with invasive ductal BC including tumor centrum (TU-C), tumor invasive front (TU-IF), lymph node metastasis (LNM), and CD45-depleted blood (CD45-DB). Expression of miRNA and mRNA was quantified by RT-PCR arrays and associations with clinico-pathological characteristics were statistically evaluated by univariate and multivariate analysis.

RESULTS

We did not verify regulating associations previously described in cell lines. However, we did detect extremely high expression in LNMs from patients with distant metastasis, but without regulation by miR-205-5p. Considering the ZEB1 functions, this overexpression indicates enhancement of metastatic potential of lymphogenously disseminated BC cells. In CD45-DB samples, downregulated miR-205-5p was found in those expressing epithelial and/or mesenchymal markers (CTC+) that could contribute to insusceptibility and survival of hematogenously disseminated BC cells mediated by increased expression of several targets including .

CONCLUSIONS

miR-205-5p and potentially gene are promising candidates for markers of metastatic potential in ductal BC.

摘要

背景

乳腺癌（BC）细胞通过血液或淋巴系统传播，导致三分之一的 BC 患者发生转移性疾病。因此，我们研究了新的侵袭和转移的预后特征。

方法

我们评估了 miRNA 和上皮间质转化（EMT）基因的表达与 E-钙黏蛋白变化的关系，这些变化来自 31 例浸润性导管 BC 患者的样本，包括肿瘤中心（TU-C）、肿瘤侵袭前沿（TU-IF）、淋巴结转移（LNM）和 CD45 耗尽的血液（CD45-DB）。通过 RT-PCR 阵列定量检测 miRNA 和 mRNA 的表达，并通过单变量和多变量分析统计评估与临床病理特征的关联。

结果

我们没有验证先前在细胞系中描述的调节关联。然而，我们确实在有远处转移但不受 miR-205-5p 调节的患者的 LNM 中检测到极高的表达。考虑到 ZEB1 的功能，这种过表达表明淋巴源性播散的 BC 细胞的转移潜力增强。在 CD45-DB 样本中，那些表达上皮和/或间充质标志物（CTC+）的样本中发现下调的 miR-205-5p，这可能有助于血液播散的 BC 细胞的不敏感性和存活，这是由包括在内的多个靶标的表达增加介导的。

结论

miR-205-5p 和潜在的基因是导管 BC 转移潜力的有前途的候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/7fdf3c2114e9/ijms-23-00103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/d6e8336ae88f/ijms-23-00103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/185f1af796b8/ijms-23-00103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/b01c8baaa524/ijms-23-00103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/7fdf3c2114e9/ijms-23-00103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/d6e8336ae88f/ijms-23-00103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/185f1af796b8/ijms-23-00103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/b01c8baaa524/ijms-23-00103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48ae/8744876/7fdf3c2114e9/ijms-23-00103-g004.jpg

相似文献

1
miR-205-5p Downregulation and Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer.miR-205-5p 的下调和上调特征在浸润性导管乳腺癌患者的播散肿瘤细胞中。
Int J Mol Sci. 2021 Dec 22;23(1):103. doi: 10.3390/ijms23010103.
2
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向，增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
3
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.miR-448 通过直接靶向 E-钙黏蛋白抑制因子 ZEB1/2 抑制乳腺癌细胞的上皮-间充质转化。
Exp Biol Med (Maywood). 2018 Mar;243(5):473-480. doi: 10.1177/1535370218754848. Epub 2018 Jan 25.
4
Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.长链非编码RNA ZEB1-AS1对胃癌中miR-335-5p的下调促进肿瘤增殖和侵袭
DNA Cell Biol. 2018 Jan;37(1):46-52. doi: 10.1089/dna.2017.3926. Epub 2017 Dec 7.
5
MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.微小RNA-409-3p通过靶向乳腺癌中的锌指E盒结合蛋白1调控细胞侵袭和转移。
IUBMB Life. 2016 May;68(5):394-402. doi: 10.1002/iub.1494. Epub 2016 Apr 15.
6
LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.长链非编码 RNA ADPGK-AS1 通过激活 ZEB1 介导的上皮-间充质转化促进胰腺癌进展。
Cancer Biol Ther. 2018 Jul 3;19(7):573-583. doi: 10.1080/15384047.2018.1423912. Epub 2018 Apr 19.
7
53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.在乳腺癌中，53BP1通过微小RNA-200b/429下调ZEB1来抑制上皮-间质转化。
Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14.
8
MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer.MiR-204-5p/Six1反馈环促进乳腺癌上皮-间质转化
Tumour Biol. 2016 Feb;37(2):2729-35. doi: 10.1007/s13277-015-4039-1. Epub 2015 Sep 25.
9
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.沉默的治疗者：miR-205-5p 的上调通过间接上调 E-钙黏蛋白的表达抑制结肠癌细胞的上皮间质转化。
Cell Death Dis. 2018 Jan 19;9(2):66. doi: 10.1038/s41419-017-0102-8.
10
Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.抑癌 miR-128-3p 通过靶向 ZEB1 抑制食管鳞癌的转移和上皮间质转化。
Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):171-180. doi: 10.1093/abbs/gmx132.

引用本文的文献

1
Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments.早期乳腺癌中的循环肿瘤生物标志物：特征、检测及临床进展
Front Oncol. 2023 Oct 24;13:1288077. doi: 10.3389/fonc.2023.1288077. eCollection 2023.
2
Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis.循环 microRNAs 用于卵巢癌的早期诊断：系统评价和荟萃分析。
Biomolecules. 2023 May 22;13(5):871. doi: 10.3390/biom13050871.
3
The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy.

本文引用的文献

1
miR-205 in Breast Cancer: State of the Art.miR-205 在乳腺癌中的研究进展。
Int J Mol Sci. 2020 Dec 22;22(1):27. doi: 10.3390/ijms22010027.
2
MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.微小RNA-200c通过靶向ZEB2（一种上皮-间质转化调节因子）抑制三阴性乳腺癌的转移。
Ann Clin Lab Sci. 2020 Jul;50(4):519-527.
3
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.EMT相关转录因子ZEB1在乳腺癌中的致癌功能
通过表观遗传调控看肿瘤转移过程：癌症治疗的广阔前景。
Int J Mol Sci. 2022 Dec 7;23(24):15446. doi: 10.3390/ijms232415446.
4
Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?循环肿瘤细胞在乳腺癌中的临床相关性：上皮或间充质特征、单细胞或细胞簇？
Int J Mol Sci. 2022 Oct 12;23(20):12141. doi: 10.3390/ijms232012141.
5
miRNA in Molecular Diagnostics.分子诊断中的微小RNA
Bioengineering (Basel). 2022 Sep 9;9(9):459. doi: 10.3390/bioengineering9090459.
6
The Prognostic Value of the Circulating Tumor Cell-Based Four mRNA Scoring System: A New Non-Invasive Setting for the Management of Bladder Cancer.基于循环肿瘤细胞的四种mRNA评分系统的预后价值：一种用于膀胱癌管理的新型非侵入性方法
Cancers (Basel). 2022 Jun 25;14(13):3118. doi: 10.3390/cancers14133118.
J Transl Med. 2020 Feb 3;18(1):51. doi: 10.1186/s12967-020-02240-z.
4
CTCs Expression Profiling for Advanced Breast Cancer Monitoring.用于晚期乳腺癌监测的循环肿瘤细胞表达谱分析
Cancers (Basel). 2019 Dec 4;11(12):1941. doi: 10.3390/cancers11121941.
5
MiR-205 Dysregulations in Breast Cancer: The Complexity and Opportunities.乳腺癌中miR-205的失调：复杂性与机遇
Noncoding RNA. 2019 Nov 19;5(4):53. doi: 10.3390/ncrna5040053.
6
MicroRNAs Contribute to Breast Cancer Invasiveness.微小 RNA 促进乳腺癌侵袭性。
Cells. 2019 Oct 31;8(11):1361. doi: 10.3390/cells8111361.
7
MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.miRNA-221-5p 通过调节 E-钙黏蛋白的表达促进乳腺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6983-6990. doi: 10.26355/eurrev_201908_18738.
8
E-cadherin is required for metastasis in multiple models of breast cancer.E-钙黏蛋白是多种乳腺癌模型转移所必需的。
Nature. 2019 Sep;573(7774):439-444. doi: 10.1038/s41586-019-1526-3. Epub 2019 Sep 4.
9
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.微小RNA-124基于锌指E盒结合同源盒蛋白2靶点调控上皮-间质转化，以抑制三阴性乳腺癌的侵袭和转移。
Pathol Res Pract. 2019 Apr;215(4):697-704. doi: 10.1016/j.prp.2018.12.039. Epub 2018 Dec 31.
10
The roles of ZEB1 in tumorigenic progression and epigenetic modifications.ZEB1 在肿瘤发生进展和表观遗传修饰中的作用。
Biomed Pharmacother. 2019 Feb;110:400-408. doi: 10.1016/j.biopha.2018.11.112. Epub 2018 Dec 5.